This Biotech June Catalyst: What Investors Need to Know Now
A major fund trimmed its stake in a biotech ahead of a June FDA milestone. This article explains what that means for ...
Find out when funds are available after a deposit, including standard windows and factors that can affect arrival times.
21,612 articlesA major fund trimmed its stake in a biotech ahead of a June FDA milestone. This article explains what that means for ...
A 58-year-old accountant tests whether a portfolio built on JEPI and SPYI can replace a $90,000 salary. The plan hing...
A fresh government outlook puts social security's insolvency date at the end of 2032, prompting talks of payroll tax ...
When inflation heats up, investors often pause to reconsider where new money goes. This guide breaks down how VOO and...
A five-year plumbing dispute in a premium Manhattan co-op escalates into questions about the building’s finances. Thi...
As the AI rally continues, XNTK’s 35-stock equal-weight tech approach is being weighed against QQQ’s Nasdaq-100 expos...
A notable stake sale in Arcellx turned heads in biotech investing. This article unpack the $26 million exit, why the ...
JPMorgan Chase is tightening its lending standards for private deals while a $33 billion private credit fund faces he...
NVIDIA's Huang warns of a potential AI leadership shift as Huawei accelerates its chip ambitions. Markets react as in...
A standout move in the world of investing: a wealth manager makes a sizable bet on an active international rotation E...
Bitcoin investment products suffer $1.44 billion in net outflows, marking the heaviest weekly drain in 2026 and signa...
When the AI stock chorus gets loud, picking one winner feels daunting. This article explains why a low-cost AI ETF ca...